Hepatitis B virus: where are we and where are we going?

Methods Mol Med. 2004:96:415-43. doi: 10.1385/1-59259-670-3:415.
No abstract available

Publication types

  • Review

MeSH terms

  • Antiviral Agents / economics
  • Antiviral Agents / therapeutic use
  • Genotype
  • Hepatitis B / drug therapy
  • Hepatitis B / epidemiology
  • Hepatitis B / transmission
  • Hepatitis B virus / genetics
  • Hepatitis B virus / physiology*
  • Humans

Substances

  • Antiviral Agents